Details of the Drug

General Information of Drug (ID: DM13YK0)

Drug Name

Ferroportin mab

Indication

Disease Entry	ICD 11	Status	REF
Anemia	3A00-3A9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Solute carrier family 40 member 1 (SLC40A1)	TT6Y1PG	S40A1_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease

Anemia

ICD Disease Classification

3A00-3A9Z

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Solute carrier family 40 member 1 (SLC40A1)	DTT	SLC40A1	6.38E-02	0.15	0.5

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01991483) A Study of LY2928057 in Hemodialysis Participants. U.S. National Institutes of Health.
2	The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci. 2014 March; 35(3): 155-161.